Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • World Cup Coverage
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Eli Lilly to Buy Psychedelic Firm AtaiBeckley

Digest more
Top News
Overview
Impacts
 · 10h · on MSN
Lilly enters psychedelic drug race with up to $3.8 billion AtaiBeckley deal
By Puyaan Singh and Kunal Das July 16 (Reuters) - Eli Lilly will buy AtaiBeckley for up to $3.8 billion, the company said on Thursday, joining a race among pharma majors to develop psychedelic treatments for depression and other mental health conditions.

Continue reading

 · 1d
Under the Radar: Psychedelic-Drug Stock Soars on Eli Lilly Deal
 · 9h
Eli Lilly is acquiring psychedelic drug developer AtaiBeckley for $3.8 billion
 · 7h
Eli Lilly to Buy Psychedelic Firm AtaiBeckley for Initial $2.8 Billion
Eli Lilly LLY 0.35% has struck a deal to buy mental-health-focused AtaiBeckley ATAI -5.47% for an initial $2.8 billion, continuing the drugmaker’s recent buying spree.

Continue reading

 · 13h
Eli Lilly buys psychedelic biotech backed by Peter Thiel
 · 11h
Lilly Strikes $3.8 Billion Deal for Psychedelic Drugmaker
 · 7h
🔎 Under the Radar: Psychedelic-Drug Stock Soars on Eli Lilly Deal
Eli will pay $6.75 a share in cash for the biopharma company, a 26% premium to yesterday's closing price of $5.36.

Continue reading

 · 11h
AtaiBeckley jumps 30% as Eli Lilly agrees to buy psychedelic firm for up to $3.8B
EconoTimes · 23h
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
MedPage Today on MSN
1d

FDA's psychedelic guidance; mass shootings and car crashes; ADHD drug misuse down

News and commentary from the psychiatry world
2d

While the FDA finalizes how to test drugs it treats like heroin, Mass. eyes psychedelic therapy

FDA finalized new guidance for testing MDMA and psilocybin in trials, days after Massachusetts advanced its own psychedelic therapy pilot.
7don MSN

Psychedelic drug screen in mice may overlook stress and brain changes

Over the past decades, some medical researchers and neuroscientists have been exploring the possible therapeutic effects of psychedelic compounds, such as lysergic acid diethylamide (LSD) and psilocybin.
Reuters
1y

Federal Regulation of Psychedelic Therapies

A discussion of the federal legal and regulatory framework that controls the research, approval, and marketing of psychedelic drug products, including the role of the Food and Drug Administration (FDA) and the Drug Enforcement Administration (DEA) in ...
3d

7 Best Psychedelic Stocks to Buy According to Analysts

As the psychedelic drug industry shifts from a speculative niche to a potential part of mainstream healthcare, investors have started to keep a careful eye on it.
8d

FDA cracks down on illegal ketamine sellers amid nearing ‘psychedelic revolution’

The agency is taking action to curb the illicit online trade of unregulated and unapproved ketamine products through a slew of warning letters.
World Cup Coverage
The latest news on World Cup
See more
  • Privacy
  • Terms